공시 • May 16
CME Group Launches Nasdaq CME Crypto Index Futures CME Group, the world's leading derivatives marketplace, announced plans to launch Nasdaq CME Crypto Index futures on June 8, pending regulatory review. Nasdaq CME Crypto Index futures will be the company's first-ever market-cap weighted futures contract, and available to trade in both micro-sized and larger-sized contracts. These contracts will provide market participants with a capital-efficient way to gain exposure to the top cryptocurrencies by market cap – all through a single, financially settled futures contract. At expiration, Nasdaq CME Crypto Index futures will be financially-settled to the value of the Nasdaq CME Crypto Settlement Price Index, which measures the performance of the largest and most actively traded cryptocurrencies, and currently includes (as of May 14) bitcoin, ether, SOL, XRP, ADA, LINK, and lumens. Nasdaq CME Crypto Index futures will be listed on and subject to the rules of CME. 공시 • May 09
CME Group Announces New Avalanche and Sui Cryptocurrency Futures CME Group, the world's leading derivatives marketplace, announced its new Avalanche (AVAX) and Sui (SUI) futures are now available for trading. First trades were executed as blocks between FalconX and G-20 Group. CME GroupCryptocurrency futures and options will be available for trading 24 hours a day, seven days a week, beginning May 29. For more information on AVAX and SUI futures, as well as the full CME GroupCryptocurrency suite, please visit cmegroup.com/cryptolaunch. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 공시 • Apr 17
Depository Trust & Clearing Corporation and CME Group Receive Regulatory Approvals to Launch Expanded U.S. Treasury Cross-Margining Arrangement for End-User Clients Depository Trust & Clearing Corporation and CME Group had their expanded cross-margining arrangement, designed to create additional capital efficiencies for market participants, receive regulatory approvals from the U.S. Securities and Exchange Commission and the Commodity Futures Trading Commission. Beginning April 30, Depository Trust & Clearing Corporation and CME Group will extend the benefits of cross-margining to end-user clients of dually registered broker/dealers and futures commission merchants that are common members of both the Depository Trust & Clearing Corporation's Fixed Income Clearing Corporation and CME. Clients can benefit from increased capital and margin efficiencies when clearing transactions in U.S. Treasury securities through Fixed Income Clearing Corporation and interest rate futures through CME when those transactions have offsetting risk exposures. Clients active in trading U.S. Treasury and interest rate derivatives will be able to offset eligible positions across both clearinghouses, reducing margin requirements, freeing up capital and improving liquidity. CME-Fixed Income Clearing Corporation cross-margining arrangements have been available to common clearing members with respect to their proprietary accounts since 2004, with significant enhancements to the arrangement announced in 2024. This latest expansion will now enable clearing members to extend equivalent margining benefits to their clients. Under the arrangement, Fixed Income Clearing Corporation will designate cross-margin accounts, allowing all eligible positions in the account to offset with eligible CME Group interest rate futures. CME Clearing allows participants to direct futures to end-user cross-margin accounts throughout the day, thereby making them available for offset in the cross-margin arrangement. 공시 • Apr 16
Cme Group Expands Equity Index Dividend Suite with New Mid-Curve Options and Quarterly Futures CME Group, the world's leading derivatives marketplace, announced plans to expand its Equity Index Dividend suite on May 11, with the addition of Mid-curve options on S&P 500 Annual Dividend Index futures, alongside Nasdaq-100 and Russell 2000 Quarterly Dividend Index futures, pending regulatory review. These new products are the latest addition to CME Group's deeply liquid Equity Index Dividend suite, which includes: Options on S&P 500 Annual Dividend futures; S&P 500 Annual and Quarterly Dividend Index futures; Nasdaq-100 Annual Dividend Index futures; and Russell 2000 Annual Dividend Index futures. Year-to-date trading highlights include: Dividend futures and options open interest of 860,000 contracts, up 27% year-over-year. S&P 500 Quarterly Dividend Index futures average daily volume (ADV) up 21% year-over-year. Options on S&P Annual Dividend Index futures ADV of 3,900 contracts, up 80% year-over-year. These products will be listed on and subject to the rules of CME. 공시 • Apr 14
CME Group Announces to Launch Options on Eris SOFR Swap Futures on June 16, 2026, Pending Regulatory Review CME Group announced it will launch options on Eris SOFR Swap futures on June 16, 2026, pending regulatory review. Eris SOFR Swap options will complement the existing interest rate product suite, which delivers deep liquidity, price transparency and unmatched margin efficiencies to global market participants. Eris SOFR Swap options will help institutional investors manage risk with greater precision as they navigate varying expectations on the direction of U.S. interest rates. By mirroring the structure of forward-premium OTC swaptions, Eris SOFR Swap options can deliver cost optimization, margin efficiencies and trading simplicity amid shifting economic conditions. From the beginning, the goal of Eris was to rethink how swap spread risk could be accessed, combining the precision of OTC markets with the efficiency of futures. Because of these unique design characteristics, the product has obtained significant adoption by a wide range of market participants. CME Group's addition of options will enable more sophisticated risk management strategies while preserving the capital and liquidity advantages that have driven the impressive growth of Eris SOFR Swap futures. Eris SOFR Swap options will enable clients to better manage the convexity of their portfolios, while providing a flexible, capital-efficient extension of risk management solutions at CME Group. CME Group is the world's leading interest rate market, offering futures and options for a broad range of benchmark products, including U.S. Treasuries, SOFR, Fed Funds, TBAs, credit and more. Its U.S. Treasury and SOFR contracts trade side-by-side on the CME Globex platform with BrokerTec cash securities. Since launching in October 2020, more than 10 million Eris SOFR Swap futures contracts have traded at CME Group. In March 2026, Eris SOFR Swap futures reached an all-time open interest record of 707,000 contracts ($71B notional), including a single-day volume record of 299,513 contracts on March 10. Eris SOFR Swap futures replicate interest rate swap cash flows, offering the standardization and capital savings of exchange-traded instruments. The addition of options on 2-year, 5-year and 10-year Eris SOFR Swap futures will support more sophisticated hedging strategies, such as managing non-linear risk in mortgage-backed portfolios. Eris SOFR Swap options will be eligible for margin offsets with other cleared interest rate futures and options at CME Group. The products will be listed by, and subject to, the rules of CBOT. 
